141 related articles for article (PubMed ID: 10069488)
1. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
Gharehbaghi K; Zhen W; Fritzer-Szekeres M; Szekeres T; Jayaram HN
Life Sci; 1999; 64(2):103-12. PubMed ID: 10069488
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
Ford H; Cooney DA; Ahluwalia GS; Hao Z; Rommel ME; Hicks L; Dobyns KA; Tomaszewski JE; Johns DG
Cancer Res; 1991 Jul; 51(14):3733-40. PubMed ID: 1712247
[TBL] [Abstract][Full Text] [Related]
3. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
Ford H; Driscoll JS; Hao Z; Dobyns KA; Rommel ME; Stowe E; Anderson JO; Plowman J; Waud WR; Johns DG
Biochem Pharmacol; 1995 Jan; 49(2):173-80. PubMed ID: 7840794
[TBL] [Abstract][Full Text] [Related]
4. Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo.
Gharehbaghi K; Szekeres T; Yalowitz JA; Fritzer-Szekeres M; Pommier YG; Jayaram HN
Life Sci; 2000 Nov; 68(1):1-11. PubMed ID: 11132239
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
Agbaria R; Kelley JA; Jackman J; Viola JJ; Ram Z; Oldfield E; Johns DG
Oncol Res; 1997; 9(3):111-8. PubMed ID: 9220496
[TBL] [Abstract][Full Text] [Related]
6. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors.
Viola JJ; Agbaria R; Walbridge S; Oshiro EM; Johns DG; Kelley JA; Oldfield EH; Ram Z
Cancer Res; 1995 Mar; 55(6):1306-9. PubMed ID: 7882327
[TBL] [Abstract][Full Text] [Related]
7. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
Zhang H; Cooney DA; Zhang MH; Ahluwalia G; Ford H; Johns DG
Cancer Res; 1993 Dec; 53(23):5714-20. PubMed ID: 7694793
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity.
Schimmel KJ; Gelderblom H; Guchelaar HJ
Curr Cancer Drug Targets; 2007 Aug; 7(5):504-9. PubMed ID: 17691910
[TBL] [Abstract][Full Text] [Related]
9. Cyclopentenyl cytosine and neuroblastoma SK-N-BE(2)-C cell line cells.
Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
Eur J Cancer; 1995; 31A(4):627-31. PubMed ID: 7576983
[TBL] [Abstract][Full Text] [Related]
10. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of tiazofurin in human colon carcinoma HT-29.
Zhen W; Jayaram HN; Weber G
Cancer Invest; 1992; 10(6):505-11. PubMed ID: 1358409
[TBL] [Abstract][Full Text] [Related]
12. Measurement of cyclopentenyl cytosine 5'-triphosphate in vitro and in vivo by multidimensional high-performance liquid chromatography.
Agbaria R; Ford H; Kelley JA; Xie F; Politi P; Grem JL; Cooney DA; Marquez VE; Allegra CJ; Johns DG
Anal Biochem; 1993 Aug; 213(1):90-6. PubMed ID: 8238887
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
[TBL] [Abstract][Full Text] [Related]
15. The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines.
Bierau J; van Gennip AH; Helleman J; van Kuilenburg AB
Biochem Pharmacol; 2001 Oct; 62(8):1099-105. PubMed ID: 11597578
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells.
Bierau J; van Gennip AH; Leen R; Caron HN; van Kuilenburg AB
FEBS Lett; 2002 Sep; 527(1-3):229-33. PubMed ID: 12220665
[TBL] [Abstract][Full Text] [Related]
17. The effect of cyclopentenyl cytosine on human SK-N-BE(2)-C neuroblastoma cells.
Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
Biochem Pharmacol; 1995 Jul; 50(2):277-9. PubMed ID: 7632174
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells.
Glazer RI; Knode MC; Lim MI; Marquez VE
Biochem Pharmacol; 1985 Jul; 34(14):2535-9. PubMed ID: 4015694
[TBL] [Abstract][Full Text] [Related]
19. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Huang M; Wang Y; Collins M; Graves LM
Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935
[TBL] [Abstract][Full Text] [Related]
20. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
Verschuur AC; Brinkman J; Van Gennip AH; Leen R; Vet RJ; Evers LM; Voûte PA; Van Kuilenburg AB
Leuk Res; 2001 Oct; 25(10):891-900. PubMed ID: 11532523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
